On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Drugs for Neglected Diseases Initiative

InstitutionResearch output, impact & collaborations

Drugs for Neglected Diseases Initiative is a institution indexed in ScholarIQ from OpenAlex.

What is known about Drugs for Neglected Diseases Initiative?

ScholarIQrecord summary

Drugs for Neglected Diseases Initiative is a research organisation in Geneva, Switzerland. OpenAlex records 1,296 works and 83,353 citations for it. 1 researchers list it as their most recent affiliation.

How many works does Drugs for Neglected Diseases Initiative have?

ScholarIQindexed works

Drugs for Neglected Diseases Initiative has 1,296 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Drugs for Neglected Diseases Initiative have?

ScholarIQcitation count

Drugs for Neglected Diseases Initiative has 83,353 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Drugs for Neglected Diseases Initiative?

ScholarIQresearcher count

Drugs for Neglected Diseases Initiative has 1 researchers in the ScholarIQ index.

What is the average h-index at Drugs for Neglected Diseases Initiative?

ScholarIQavg h-index

Drugs for Neglected Diseases Initiative has an average h-index of 64 in OpenAlex.

What is the ROR of Drugs for Neglected Diseases Initiative?

ScholarIQror

The ROR for Drugs for Neglected Diseases Initiative is on the source record.

What is the OpenAlex record for Drugs for Neglected Diseases Initiative?

ScholarIQopenalex

The OpenAlex for Drugs for Neglected Diseases Initiative is on the source record.

Who are the most-cited researchers behind Drugs for Neglected Diseases Initiative?

ScholarIQtop researchers by citations
1
Samuel Kariuki · Salmonella and Campylobacter epidemiology
450 works21,692 citations

What are the most-cited papers on Drugs for Neglected Diseases Initiative?

ScholarIQmost cited works
Distinct Salmonella Enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settings
Nicholas Feasey, James Hadfield, Karen H. Keddy, Timothy J. Dallman, Jan Jacobs, Xiangyu Deng, Paul Wigley, Lars Barquist, Gemma C. Langridge, Theresa Feltwell, Simon R. Harris, Alison E. Mather, María Fookes, Martin Aslett, Chisomo Msefula, Samuel Kariuki, Calman A. MacLennan, Robert Onsaŕe, François‐Xavier Weill, Simon Le Hello, Anthony M. A. Smith, Michael McClelland, Prerak Desai, Christopher M. Parry, J. Cheesbrough, Neil French, Josefina Campos, José A. Chabalgoity, Laura Betancor, Katie L. Hopkins, Satheesh Nair, Tom J Humphrey, Octavie Lunguya, Tristan A. Cogan, Milagritos D. Tapia, Samba O. Sow, Sharon M. Tennant, Kristin Bornstein, Myron M. Levine, Lizeth Lacharme‐Lora, Dean Everett, Robert A. Kingsley, Julian Parkhill, Robert S. Heyderman, Gordon Dougan, Melita A. Gordon, Nicholas R. Thomson
Nature Genetics. 2016223 CitationsOPEN ACCESS

How much of the research on Drugs for Neglected Diseases Initiative is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
100%
Bronze
0%
Closed
0%
470M+ articles · free account